These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26995804)

  • 1. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
    [No Abstract]   [Full Text] [Related]  

  • 3. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
    [No Abstract]   [Full Text] [Related]  

  • 6. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Oct; 91(42):485-99. PubMed ID: 27766828
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Mar; 91(10):121-32. PubMed ID: 26971356
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
    Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Mar; 90(11):97-108. PubMed ID: 25771542
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
    Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Oct; 91(41):469-84. PubMed ID: 27758094
    [No Abstract]   [Full Text] [Related]  

  • 13. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence of infection with avian, human, and swine influenza viruses in pigs in Cairo, Egypt.
    Gomaa MR; Kandeil A; El-Shesheny R; Shehata MM; McKenzie PP; Webby RJ; Ali MA; Kayali G
    Arch Virol; 2018 Feb; 163(2):359-364. PubMed ID: 29075888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
    Qi X; Lu C
    Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.